Ilmu Komputer & AI editorial
Open AccessOA2022
Machine Learning for Multi-Omics Data Integration in Cancer
This review categorizes machine learning tools for multi-omics integration into general-purpose and task-specific approaches, benchmarks five methods on Cancer Cell Line Encyclopedia data for cancer type classification and drug response prediction, and provides guidance for method selection.
Zhaoxiang Cai; R. Poulos; Jia Liu; Qing Zhongยท iScienceยท 2022ยท DOI 10.1016/j.isci.2022.103798
The core problem
Multi-omics data analysis has become a cornerstone of cancer molecular biology, enabling ground-breaking discoveries by integrating genomics, transcriptomics, proteomics, and other omics layers. The complexity and volume of such data necessitate automated computational approaches. Machine learning (ML) methods have been developed to integrate omics data, but the landscape is diverse, with tools varying in purpose, learning paradigm, and performance. This review aims to categorize ML tools for multi-omics integration, benchmark representative methods, and offer recommendations for researchers. The authors emphasize that improved data integration methodologies are essential for drug discovery, clinical trial design, and personalized treatments.
Innovation
The authors classify ML tools into two main categories: general-purpose and task-specific. General-purpose methods are designed for broad integration tasks, while task-specific methods are tailored to specific biological questions such as cancer subtype discovery or drug response prediction. Both supervised and unsupervised learning approaches are covered. To assess performance, the authors benchmark five ML approaches using data from the Cancer Cell Line Encyclopedia (CCLE). The evaluation metrics include accuracy for cancer type classification, mean absolute error (MAE) for drug response prediction, and runtime efficiency. The specific methods benchmarked are not detailed in the summary, but the benchmarking framework is designed to be reproducible and informative for method selection.
Introduction
Multi-omics data analysis has become a cornerstone of cancer molecular biology, enabling ground-breaking discoveries by integrating genomics, transcriptomics, proteomics, and other omics layers. The complexity and volume of such data necessitate automated computational approaches. Machine learning (ML) methods have been developed to integrate omics data, but the landscape is diverse, with tools varying in purpose, learning paradigm, and performance. This review aims to categorize ML tools for multi-omics integration, benchmark representative methods, and offer recommendations for researchers. The authors emphasize that improved data integration methodologies are essential for drug discovery, clinical trial design, and personalized treatments.
Why it matters
The review discusses the strengths and limitations of general-purpose versus task-specific ML methods. General-purpose tools offer flexibility but may lack the precision of task-specific approaches, which are optimized for particular objectives. The authors recommend that researchers select methods based on their specific applications, considering factors such as data type, sample size, and computational resources. They also highlight the need for novel ML methodologies that can handle the increasing complexity and heterogeneity of multi-omics data. Such advancements will be crucial for translating multi-omics insights into clinical applications, including drug discovery, clinical trial design, and personalized treatments. The review concludes by advocating for continued development and benchmarking of integration methods to ensure robustness and reproducibility.
Who should read this
Pembaca Research Digest dan praktisi rumpun ini.
Opening member contentโฆ